JP Stock MarketDetailed Quotes
4884 Kringle Pharma
- 1118
- -122-9.84%
20min DelayMarket Closed Jun 28 15:00 JST
7.35BMarket Cap-7055P/E (Static)
1257High1055Low1.22MVolume1251Open1240Pre Close1.38BTurnover132852wk High25.70%Turnover Ratio6.57MShares39452wk Low-160.04EPS TTM5.31BFloat Cap1780Historical HighLossP/E (Static)4.75MShs Float394Historical Low-158.46EPS LYR16.29%Amplitude--Dividend TTM3.16P/B100Lot Size--Div YieldTTM
About Kringle Pharma Company
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases.
Company Profile
Symbol4884
Company NameKringle Pharma
Founded2001-12-21
Fiscal Year Ends09-30
Address7-7-15 Saitoasagi 207 Saito Bio-Incubator
Zip Code567-0085
Phone072-641-8739
Websitewww.kringle-pharma.com
Company Executives
- Name
- Position
- Salary
- Yoshiyuki Kayano
- Director and Reliability Assurance Manager
- --
- Yoshikazu Adachi
- Representative Director and President
- --
- Koichi Murakami
- Director and Director of Business Administration
- --
- Daima Hayata
- Director, Director of Pharmaceutical Development and Director of Pharmaceutical Affairs
- --
- Tomoho Masataku
- Director
- --
- Koichiro Yoshino
- Independent Director
- --
- Masato Fukui
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg